Y-mAbs

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Y-mAbs and other ETFs, options, and stocks.

About YMAB

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory.

CEO

Michael Rossi

CEOMichael Rossi

Employees

107

Employees107

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2015

Founded2015

Employees

107

Employees107

YMAB Key Statistics

Market cap

386.91M

Market cap386.91M

Price-Earnings ratio

-17.20

Price-Earnings ratio-17.20

Dividend yield

—

Dividend yield—

Average volume

3.01M

Average volume3.01M

High today

$8.52

High today$8.52

Low today

$8.51

Low today$8.51

Open price

$8.52

Open price$8.52

Volume

482.84K

Volume482.84K

52 Week high

$16.11

52 Week high$16.11

52 Week low

$3.55

52 Week low$3.55

Analyst ratings

100%

of 11 ratings

Buy

Hold

100%

Sell

People also own

Based on the portfolios of people who own YMAB. This list is generated using Robinhood data, and it’s not a recommendation.

Y-mAbs

Why Robinhood?

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Show more

YMAB Key Statistics

Analyst ratings

100%

People also own

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory.